Holen Sie sich die Stockscreener-App
0.8999
1.10%
-0.01
Vorhandelsmarkt:
.88
-0.0199
-2.21%
Schlusskurs vom Vortag:
$0.9099
Offen:
$0.9137
24-Stunden-Volumen:
46,810
Relative Volume:
0.40
Marktkapitalisierung:
$42.15M
Einnahmen:
$10.85M
Nettoeinkommen (Verlust:
$-51.31M
KGV:
-1.221
EPS:
-0.737
Netto-Cashflow:
$-40.15M
1W Leistung:
+7.12%
1M Leistung:
+27.84%
6M Leistung:
-50.28%
1J Leistung:
-63.27%
1-Tages-Spanne:
$0.86
$0.92
1-Wochen-Bereich:
$0.812
$1.02
52-Wochen-Spanne:
$0.63
$2.565
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
0.8999 | 42.62M | 10.85M | -51.31M | -40.15M | -0.737 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-02 | Eingeleitet | Maxim Group | Buy |
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
InspireMD Q2 2026 Earnings: Revenue Misses $1.77 Million Estimate - Sci-Tech Today
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $4 - Moomoo
InspireMD total revenue down 0.4% to USD 1,771,000 in Q2 2026 - Medical Buyer
Form 8K InspireMD Inc For: 17 August By Investing.com - Investing.com South Africa
InspireMD Q2 revenue holds at $1.8 million - grafa.com
InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com Nigeria
InspireMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
symbol__ Stock Quote Price and Forecast - CNN
InspireMD reports Q2 2026 revenue $1.77M, net loss $14.3M; cash & marketable securities $30.4M - TradingView
InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss - Quiver Quantitative
InspireMD (NSPR) recall turns U.S. sales negative — and deepens quarterly loss - Stock Titan
InspireMD Q2 Operating Expenses USD 13.671 Mi - Moomoo
InspireMD earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
InspireMD (NSPR) Surges 16.97% to $0.98, Pushing Toward Key ResistanceSentiment Shift - Vinanet
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Moomoo
InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk - Stock Titan
InspireMD Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
InspireMD (NSPR) Dips 3.26% to $0.83, Pressing Against Key SupportVolatility Smirk - Vinanet
InspireMD (NSPR.US) is scheduled to release its financial report on August 17. - Moomoo
InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set - scanx.trade
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan
Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k - webull.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Approves 221,666 Restricted Shares for New Hire - Stock Titan
InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates - Kalkine
NSPR Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Shares HigherReturn On Equity - Vinanet
InspireMD (NSPR) Gains 5.73% to $0.72, Pressing Toward Key Resistance at $0.76BPI Reversal - Vinanet
InspireMD (NSPR) Slides 3.68% to $0.65 as Key Support HoldsBullish Pattern Stocks - Vinanet
Piper Sandler Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing - The Manila Times
InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com - Investing.com Nigeria
Medical-device sales leader with more than 30 years returns to InspireMD - Stock Titan
InspireMD appoints Kathleen Kennedy as global sales head - scanx.trade
InspireMD, Inc. (NASDAQ: NSPR) eliminates chief commercial officer position - Stock Titan
NSPR|InspireMD Inc|Price:0.650|Chg%:-0.024 - TradingKey
InspireMD Inc (NSPR) Income Statement - TradingKey
InspireMD Inc (NSPR) Institutional Confidence - TradingKey
InspireMD Inc (NSPR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InspireMD Inc (NSPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InspireMD Inc (NSPR) Cash Flow - TradingKey
NSPR|InspireMD Inc|Price:0.690|Chg%:+0.006 - TradingKey
InspireMD Inc. Revenue Breakdown – NASDAQ:NSPR - TradingView
InspireMD (NSPR) Edges Lower as Stock Tests Key Support Near $0.65Synthetic Long - Vinanet
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):